SK30394A3 - Derivatives of 2,4-diamino-3-hydroxycarboxylic acid, method of their preparation, pharmaceutical compositions containing these derivatives and their use - Google Patents

Derivatives of 2,4-diamino-3-hydroxycarboxylic acid, method of their preparation, pharmaceutical compositions containing these derivatives and their use Download PDF

Info

Publication number
SK30394A3
SK30394A3 SK303-94A SK30394A SK30394A3 SK 30394 A3 SK30394 A3 SK 30394A3 SK 30394 A SK30394 A SK 30394A SK 30394 A3 SK30394 A3 SK 30394A3
Authority
SK
Slovakia
Prior art keywords
group
formula
hydroxy
compound
optionally substituted
Prior art date
Application number
SK303-94A
Other languages
English (en)
Slovak (sk)
Inventor
Andreas Billich
Brigitte Charpiot
Peter Ettmayer
Hubert Gstach
Philipp Lehr
Dieter Scholz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939305144A external-priority patent/GB9305144D0/en
Priority claimed from GB939319667A external-priority patent/GB9319667D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SK30394A3 publication Critical patent/SK30394A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/16—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms
    • C07D277/74—Sulfur atoms substituted by carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK303-94A 1993-03-12 1994-03-11 Derivatives of 2,4-diamino-3-hydroxycarboxylic acid, method of their preparation, pharmaceutical compositions containing these derivatives and their use SK30394A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305144A GB9305144D0 (en) 1993-03-12 1993-03-12 Organic compounds
GB939319667A GB9319667D0 (en) 1993-09-23 1993-09-23 Organic compounds

Publications (1)

Publication Number Publication Date
SK30394A3 true SK30394A3 (en) 1995-03-08

Family

ID=26302578

Family Applications (1)

Application Number Title Priority Date Filing Date
SK303-94A SK30394A3 (en) 1993-03-12 1994-03-11 Derivatives of 2,4-diamino-3-hydroxycarboxylic acid, method of their preparation, pharmaceutical compositions containing these derivatives and their use

Country Status (16)

Country Link
US (1) US5538997A (no)
EP (1) EP0615969A1 (no)
JP (1) JP3987586B2 (no)
KR (1) KR940021515A (no)
CN (1) CN1104209A (no)
AU (1) AU672867B2 (no)
CA (1) CA2118876A1 (no)
CZ (1) CZ55394A3 (no)
FI (1) FI941149A (no)
HU (1) HUT71793A (no)
IL (1) IL108930A0 (no)
NO (1) NO940844L (no)
NZ (1) NZ260063A (no)
PE (1) PE15695A1 (no)
SK (1) SK30394A3 (no)
TW (1) TW260662B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US5872101A (en) * 1995-01-06 1999-02-16 Sibia Neurosciences, Inc. Methods of treating neurodegenerative disorders using protease inhibitors
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
ATE218538T1 (de) 1995-11-21 2002-06-15 Novartis Erfind Verwalt Gmbh Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
CA2370830C (en) * 1999-04-27 2009-10-13 Novartis Ag Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
GB0012795D0 (en) * 2000-05-25 2000-07-19 Novartis Ag Organic compounds
AR035720A1 (es) * 2000-12-20 2004-07-07 Bristol Myers Squibb Pharma Co Derivados de amida ,composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de quimioquinas
WO2003006021A1 (en) * 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
CA2052892A1 (en) * 1990-10-11 1992-04-12 Suresh K. Balani Inhibitors of hiv protease
MX9203836A (es) * 1991-07-02 1993-01-01 Sandoz Ag Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion.
GB9210744D0 (en) * 1992-05-20 1992-07-08 Pfizer Ltd Antiviral peptides

Also Published As

Publication number Publication date
FI941149A0 (fi) 1994-03-10
JP3987586B2 (ja) 2007-10-10
NZ260063A (en) 1996-02-27
AU5773794A (en) 1994-09-15
NO940844L (no) 1994-09-13
TW260662B (no) 1995-10-21
IL108930A0 (en) 1994-06-24
NO940844D0 (no) 1994-03-10
EP0615969A1 (en) 1994-09-21
US5538997A (en) 1996-07-23
HUT71793A (en) 1996-02-28
CA2118876A1 (en) 1994-09-13
AU672867B2 (en) 1996-10-17
KR940021515A (ko) 1994-10-19
CN1104209A (zh) 1995-06-28
JPH0789919A (ja) 1995-04-04
PE15695A1 (es) 1995-06-13
HU9400745D0 (en) 1994-06-28
FI941149A (fi) 1994-12-22
CZ55394A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
JP3798337B2 (ja) 新規α−アミノ酸化合物、その調製方法及びそれを含有する医薬組成物
KR100187990B1 (ko) 레트로바이러스성 프로테아제 억제 화합물 제조용 합성 중간체
JP2963910B2 (ja) レトロウイルスプロテアーゼ抑制化合物
EP0082088B1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
US7521427B2 (en) Peptidyl allyl sulfones
EP0800528A1 (en) Peptide and peptide analog protease inhibitors
JP2011140488A (ja) Ｈｃｖｎｓ−３セリンプロテアーゼインヒビター
HU204847B (en) Process for producing new peptidase inhibitors
JPS5890536A (ja) レニン抑制ペプチド類
CA2571828A1 (en) Bacterial efflux pump inhibitors and methods of treating bacterial infections
CZ280292A3 (en) Novel derivatives of 5-amino-4-hydroxyhexanoic acid which derivatives act as therapeutic agents
US7132420B2 (en) Aspartic protease inhibitors
JPH04211095A (ja) 新規ジペプチド、その製造方法及び薬剤におけるレニン阻害剤としてのその使用
EP1431290A1 (en) Novel nitrogenous compound and use thereof
AU722421B2 (en) Compounds with growth hormone releasing properties
FI106466B (fi) Menetelmä terapeuttisesti käyttökelpoisten difluoristatonianalogien valmistamiseksi
JPH10509727A (ja) Ｎ−末端スルホニル−又はアミノスルホニル基を有する新規のジペプチドのｐ−アミノベンジルアミド
JPH0789988A (ja) 抗ウイルス活性を示す新規なバリン含有疑似ペプチド類
WO2007041775A1 (en) Cysteine protease inhibitors incorporating azide groups
KR19980086989A (ko) 치환된 6- 및 7- 아미노-테트라하이드로이소퀴놀린 카복실산
CA2032034A1 (en) Antiviral new peptides
SK30394A3 (en) Derivatives of 2,4-diamino-3-hydroxycarboxylic acid, method of their preparation, pharmaceutical compositions containing these derivatives and their use
JPH07500604A (ja) 高血圧治療用エチルアラニンアミノジオール化合物
EP0555479A1 (en) Epoxysuccinamic acid derivative
JP2004143053A (ja) β−アミノヒドロキサム酸誘導体およびその用途